Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 80 for “"ERCC1"”.
-
Role of DNA repair gene Ercc1 in the liver
The ERCC1/XPF complex is responsible for incision at the 5' side of the DNA lesion during nucleotide excision repair and is also involved in homologous recombination and inter-strand cross-link repair. The aim of the current study was to set up a better model for examination ofErccl deficiency in …
-
Investigation of a novel Ercc1 transcript predominant in skin
… risk of developing skin cancer. The gene ERCC1, which has an essential role in the NER pathway, has not been linked to a human disorder but mice in which the Erccl gene has been inactivated are DNA repair deficient. These mice die, prior to weaning, of liver failure.
-
Role of DNA repair protein ERCC1 in skin cancer
… and a 1000-fold increased risk of skin cancer. ERCC1 is essential for the NER pathway where it acts in a complex with the XPF protein to make the incision 5' to the DNA lesion. The normal 1.1kb Ercc1 transcript is expressed in all tissues. Our group has discovered a second larger 1.5 kb …
-
Characterizing the biophysical effects of mutations on the XPF-ERCC1 Complex
… the Biophysical Effects of Mutations on the XPF-ERCC1 Complex. UV radiation generates lesions on DNA, such as cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs), which must be repaired to preserve genetic information. The nucleotide excision repair (NER) pathway plays a critical …
-
Evaluation von ERCC1 als prädiktiver Biomarker bei mit platinbasierter Chemotherapie behandeltem Nebennierenrindenkarzinom
… Excision repair cross complementing group 1 (ERCC1) spielt eine entscheidende Rolle bei der Reparatur durch Platin entstandener DNA-Schäden. Zwei Studien die die Rolle von ERCC1 per Immunhistochemie als prädiktiver Marker für das Ansprechen auf platinbasierte Chemotherapie beim ACC …
-
Drug screening to identify inhibitors of the structure-specific endonuclease ERCC1-XPF
… Elevated levels of the DNA repair protein ERCC1, which is needed to remove cisplatin-induced DNA damage, has been found to be an indicator of poor prognosis in ovarian and lung cancer. To test our hypothesis that elevated ERCC1 levels account for an increased resistance to cisplatin in …
-
Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
<p>The human XPF (ERCC4) and ERCC1 proteins form a heterodimeric endonuclease that plays a critical role in maintaining genome stability. Mutations in the XPF gene cause several heritable disorders including Fanconi anemia (FA). This highlights the importance of DNA repair processes controlled by …
-
Genetische Polymorphismen in den DNA-Reparaturenzymen ERCC1, XPC, XPF und PCNA und ihre Assoziation zu Larynxkarzinomen
… auf neun bereits bekannte Genvarianten in ERCC1(A19007G, C8092A), PCNA (C1661G, C1684A), XPF(ERCC4) (G17103A, T26729C, A30147G und G30258A) und XPC (Poly-AT) hin untersucht. Die Genotypisierung erfolgte mithilfe der Polymerasekettenreaktion und Restriktionsfragmentlängen-Polymorphismen. Der …
-
Investigation into the importance of DNA repair gene Ercc1 in the skin and central nervous system
… with the rest of the population. In NER, ERCC1 acts in complex with XPF to make an incision 5' of the lesion and as such is essential for this damage repair process. ERCC1 is also involved in other types of repair including the repair of interstrand crosslinks and double strand breaks. …
-
Novel Insights Into The Use Of Ercc1 As A Biomarker For Response To Platinum-Based Chemotherapy In Lung Cancer
ERCC1/XPF is a DNA endonuclease with variable expression in primary tumor specimens, and has been investigated as a predictive biomarker for efficacy of platinum-based chemotherapy in non-small cell lung cancers where up to 30-60% of tumors harbor low to undetectable ERCC1 expression. The failure …
-
Μελέτη προγνωστικών και προβλεπτικών παραγόντων στον προχωρημένο ή μεταστατικό καρκίνο του τραχήλου της μήτρας που αντιμετωπίζεται με χημειοθεραπεία
… and genotyping was performed totest ERCC1, III β-tubulin, COX-2, CD4, CD8 and ERCC1 (C8092A and N118 N) and MDR1 (C3435T and G2677 T) gene polymorphisms, as possible predictive and prognostic markers. Results were statistically analyzed and correlatedwith patient characteristics and …
-
GENETIC POLYMORPHISMS IN DNA EXCISION REPAIR GENES IN RELATION TO CANCER AND CANCER THERAPIES
… the genetic polymorphisms in the NER genes, ERCC1 and XPD, and the BER genes, XRCC1 and PARP1, and found that the polymorphic variants had significantly higher frequencies in European Americans (EAs) for ERCC1 N118N (p<0.000001), XPD K751Q (p=0.006675), XRCC1 R399Q (p<0.000001) and PARP1 …
-
Μελέτη συσχέτισης της έκφρασης του γονιδίου ERCC1 σε επίπεδο mRNA και πρωτεΐνης, και των ρυθμιστικών παραγόντων του, με την επιβίωση σε ασθενείς με μη μικροκυτταρικό καρκίνο πνεύμονα
… as the primary treatment of choice in NSCLC. The ERCC1 gene has been implicated in the development of therapeutic resistance to platinum-based chemotherapy through the nucleotide excision repair mechanism (NER). In this pathway, ERCC1 binds with the XPF protein to form an endonuclease complex. …
-
Genetic changes in melanoma progression
… also regulates expression of the DNA repair gene ERCC1 following EGF treatment. ERCC1 is essential for nucleotide excision repair, which is one of the major systems for removal of cisplatin induced DNA lesions. The aims of this project were: 1, to investigate the molecular changes in our immortal …
-
Μελέτη πολυμορφισμών και έκφρασης του γονιδίου ERCC1 σε ασθενείς με προχωρημένο καρκίνο ουροθηλίου που αντιμετωπίζονται με χημειοθεραπεία βασισμένη στην πλατίνα
The association between two polymorphisms of ERCC1 gene, with the outcome after platinum-based chemotherapy in patients with advanced urothelial cancer was examined.Genotyping of C19007T and C8092A polymorphisms was determined by PCR amplification and restriction fragment length polymorphism in 113 …
-
Expression of Excision Repair Cross-Complementation Group 1 Protein Predicts Poor Outcome in Patients with Small Cell Lung Cancer
… stage: 37) were analyzed for p53, bcl-2, bax and ERCC1 expression by immunohistochemistry. All patients were treated with platinum-based doublets. The most commonly used regimen was etoposide/cisplatin (50 patients). In patients with limited stage SCLC, thoracic irradiation was performed either …
-
Prognostic Factor Analysis of Patients with Advanced Non-Small Cell Lung Cancer Treated with Palliative Chemotherapy
… stage IV were analyzed for p53, Bcl-2, Bax and ERCC1 expression by immunohistochemistry. All patients were treated with platinum-based third-generation doublet chemotherapy. RESULTS: High expression of p53, Bcl-2, Bax and ERCC1 were observed in 24 (48%), 8(16%), 32 (63%), 28 (55%) patients, …
Page 1 of 4